Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prostemics is a South Korean biotechnology company specializing in stem cell and exosome technology for regenerative medicine and cosmeceuticals. The company is best known for its proprietary AAPE (Advanced Adipose-derived stem cell Protein Extract), a line of protein-based products used globally for skin rejuvenation and hair loss treatment. Prostemics utilizes its ExoPlant platform to develop exosome-based therapeutics and drug delivery systems, including plant-derived exosome technology. Their research pipeline extends into inflammatory diseases and oncology, leveraging the regenerative and signaling properties of adipose-derived stem cells. The company is publicly traded on the KOSDAQ exchange and maintains a strong presence in the global medical aesthetics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prostemics.